| Shelly Schneider Parker, CRNA | |
|
19333 W North Ave, Brookfield, WI 53045-4132 | |
| (262) 785-2000 | |
| Not Available |
| Full Name | Shelly Schneider Parker |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 13 Years |
| Location | 19333 W North Ave, Brookfield, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467063008 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 1060733 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Columbia St Mary's Hospital Milwaukee | Milwaukee, WI | Hospital |
| Ascension Se Wisconsin Hospital - St Joseph Campus | Milwaukee, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wheaton Franciscan Medical Group Inc | 8628980943 | 594 |
News Archive
Amedisys, Inc., one of America's leading home health nursing companies, today reported its financial results for the three-month period ended March 31, 2010. We posted record financial performance with net service revenue and net income attributable to Amedisys, Inc., increasing 20.8% and 35.6%, respectively, over the three-month period ended March 31, 2009.
MacroGenics, a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced that it had administered drug to the first cohort of patients in a Phase I clinical trial of MGAH22.
Medtronic, Inc. today announced the launch of Medtronic's first mobile application for use with implantable cardiac devices. As health care shifts care delivery from outpatient to home, Medtronic is leading the implantable cardiac device industry by offering cutting-edge technology designed to give physicians greater flexibility in monitoring patient data.
Inhibiting a key immune response in mice during initial multi-drug treatment for tuberculosis could — paradoxically — shorten treatment time for the highly contagious lung infection according to new research from Johns Hopkins Children's Center and the Center for TB Research.
› Verified 1 days ago
| Entity Name | Ascension Medical Group-southeast Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609881077 PECOS PAC ID: 8628980943 Enrollment ID: O20031104000421 |
News Archive
Amedisys, Inc., one of America's leading home health nursing companies, today reported its financial results for the three-month period ended March 31, 2010. We posted record financial performance with net service revenue and net income attributable to Amedisys, Inc., increasing 20.8% and 35.6%, respectively, over the three-month period ended March 31, 2009.
MacroGenics, a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced that it had administered drug to the first cohort of patients in a Phase I clinical trial of MGAH22.
Medtronic, Inc. today announced the launch of Medtronic's first mobile application for use with implantable cardiac devices. As health care shifts care delivery from outpatient to home, Medtronic is leading the implantable cardiac device industry by offering cutting-edge technology designed to give physicians greater flexibility in monitoring patient data.
Inhibiting a key immune response in mice during initial multi-drug treatment for tuberculosis could — paradoxically — shorten treatment time for the highly contagious lung infection according to new research from Johns Hopkins Children's Center and the Center for TB Research.
› Verified 1 days ago
| Entity Name | Ascension Medical Group-southeast Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194473066 PECOS PAC ID: 8628980943 Enrollment ID: O20220620000485 |
News Archive
Amedisys, Inc., one of America's leading home health nursing companies, today reported its financial results for the three-month period ended March 31, 2010. We posted record financial performance with net service revenue and net income attributable to Amedisys, Inc., increasing 20.8% and 35.6%, respectively, over the three-month period ended March 31, 2009.
MacroGenics, a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced that it had administered drug to the first cohort of patients in a Phase I clinical trial of MGAH22.
Medtronic, Inc. today announced the launch of Medtronic's first mobile application for use with implantable cardiac devices. As health care shifts care delivery from outpatient to home, Medtronic is leading the implantable cardiac device industry by offering cutting-edge technology designed to give physicians greater flexibility in monitoring patient data.
Inhibiting a key immune response in mice during initial multi-drug treatment for tuberculosis could — paradoxically — shorten treatment time for the highly contagious lung infection according to new research from Johns Hopkins Children's Center and the Center for TB Research.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shelly Schneider Parker, CRNA W274n7018 Wrens Way, Lisbon, WI 53089-1818 Ph: (715) 292-7069 | Shelly Schneider Parker, CRNA 19333 W North Ave, Brookfield, WI 53045-4132 Ph: (262) 785-2000 |
News Archive
Amedisys, Inc., one of America's leading home health nursing companies, today reported its financial results for the three-month period ended March 31, 2010. We posted record financial performance with net service revenue and net income attributable to Amedisys, Inc., increasing 20.8% and 35.6%, respectively, over the three-month period ended March 31, 2009.
MacroGenics, a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced that it had administered drug to the first cohort of patients in a Phase I clinical trial of MGAH22.
Medtronic, Inc. today announced the launch of Medtronic's first mobile application for use with implantable cardiac devices. As health care shifts care delivery from outpatient to home, Medtronic is leading the implantable cardiac device industry by offering cutting-edge technology designed to give physicians greater flexibility in monitoring patient data.
Inhibiting a key immune response in mice during initial multi-drug treatment for tuberculosis could — paradoxically — shorten treatment time for the highly contagious lung infection according to new research from Johns Hopkins Children's Center and the Center for TB Research.
› Verified 1 days ago
Thomas M Nigro Jr., CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 19333 W North Ave, Brookfield, WI 53045 Phone: 414-290-6720 Fax: 414-290-6755 | |
Murat Calikan, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 19333 W North Ave, Brookfield, WI 53045 Phone: 414-290-6720 Fax: 414-290-6755 | |
Dana J Wilson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 19333 W North Ave, Brookfield, WI 53045 Phone: 414-290-6720 Fax: 414-290-6755 | |
James B Sweatt, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 19333 W North Ave, Brookfield, WI 53045 Phone: 414-290-6720 Fax: 414-290-6755 | |
Jill Janine Lau, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 19333 W North Ave, Brookfield, WI 53045 Phone: 262-785-2000 | |
Anne M Hollandsworth, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 19333 W North Ave, Brookfield, WI 53045 Phone: 414-290-6720 Fax: 414-290-6755 |